International Journal of Clinical Research

Objective To explore the efficacy of decitabine treatment in elderly patients with acute myeloid leukemia. Methods 54 elderly patients with acute myeloid leukemia admitted to our hospital from January 2021 to January 2022 were selected as the study subjects. The above patients were divided into a reference group and an experimental group using a random number table method, with 27 cases in each group. The former received conventional CAG treatment, while the experimental group received decitabine treatment on the basis of the above. Compare the therapeutic effects of two groups. Results The effective rate of treatment in the experimental group was significantly higher than that in the reference group (P<0.05). The recurrence rate of the experimental group was lower than that of the reference group (P<0.05). Conclusion Dexmedetomidine is effective in treating elderly patients with acute myeloid leukemia, significantly improving related symptoms and reducing disease recurrence. This treatment method is worth promoting.

Acute myeloid leukemia; Dixi Tabin; Effective treatment rate; Recurrence rate